Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

por Alsiö, Åsa, Rembeck, Karolina, Askarieh, Galia, Christensen, Peer Brehm, Färkkilä, Martti, Langeland, Nina, Rauning Buhl, Mads, Pedersen, Court, Mørch, Kristine, Haagmans, Bart L., Nasic, Salmir, Westin, Johan, Hellstrand, Kristoffer, Norkrans, Gunnar, Lagging, Martin
Publicado 2012

Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms

por Lagging, Martin, Askarieh, Galia, Negro, Francesco, Bibert, Stephanie, Söderholm, Jonas, Westin, Johan, Lindh, Magnus, Romero, Ana, Missale, Gabriele, Ferrari, Carlo, Neumann, Avidan U., Pawlotsky, Jean-Michel, Haagmans, Bart L., Zeuzem, Stefan, Bochud, Pierre-Yves, Hellstrand, Kristoffer
Publicado 2011

Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection

por Söderholm, Jonas, Waldenström, Jesper, Askarieh, Galia, Pilli, Massimo, Bochud, Pierre-Yves, Negro, Francesco, Pawlotsky, Jean-Michel, Zeuzem, Stefan, Ferrari, Carlo, Norkrans, Gunnar, Wejstål, Rune, Westin, Johan, Neumann, Avidan U., Haagmans, Bart L., Lindh, Magnus, Missale, Gabriele, Hellstrand, Kristoffer, Lagging, Martin
Publicado 2013